SCHEMBL2479941

SCHEMBL2479941

CC(C)(COCCCCBr)[SiH](c1ccccc1)c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2986949 0.95
SCHEMBL3411831 0.86 NPC1 (0.37)
SCHEMBL2415833 0.78
SCHEMBL3415811 0.76
SCHEMBL3412356 0.76
SCHEMBL598956 0.75 KDM4E (0.31)
SCHEMBL2466724 0.75 PPARD (0.35)
SCHEMBL1733641 0.75 CYP1A2 (0.31)
SCHEMBL4823005 0.74
SCHEMBL4337322 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8444955-B2 Radiofluorination methods GE HEALTHCARE LIMITED (GB) 2013-05-21 US disclosed
US-8216548-B2 Radiofluorination methods GE HEALTHCARE AS (NO) 2012-07-10 US disclosed
EP-2376432-A1 NOVEL EICOSANOID DERIVATIVES Max-Delbrück-Centrum für Molekulare Medizin (MDC) (DE) 2011-10-19 EP disclosed
US-20100196270-A1 RADIOFLUORINATION METHODS GE HEALTHCARE AS (NO) 2010-08-05 US disclosed
WO-2010081683-A1 NOVEL EICOSANOID DERIVATIVES Max-Delbrück-Centrum für Molekulare Medizin (DE) 2010-07-22 WO disclosed
EP-2195037-A2 RADIOFLUORINATION METHODS GE Healthcare UK Limited (GB) 2010-06-16 EP disclosed
US-20100034740-A1 RADIOFLUORINATION METHODS GE HEALTHCARE AS (NO) 2010-02-11 US disclosed
EP-2114464-A2 RADIOFLUORINATION METHODS GE Healthcare AS (NO) 2009-11-11 EP disclosed
WO-2009035959-A2 RADIOFLUORINATION METHODS GE HEALTHCARE LIMITED (GB) 2009-03-19 WO disclosed
WO-2008083191-A2 RADIOFLUORINATION METHODS GE HEALTHCARE AS (NO) 2008-07-10 WO disclosed